Characterization of Local Vascular Effects of LNMMA
This study has been completed.
Sponsor:
Dresden University of Technology
Information provided by:
Dresden University of Technology
ClinicalTrials.gov Identifier:
NCT00180063
First received: September 9, 2005
Last updated: November 1, 2005
Last verified: September 2005
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Characterization of an unexpected venodilative effect of higher L-NMMA-doses in dorsal human hand veins.
| Condition | Intervention |
|---|---|
|
Healthy Subjects |
Drug: L-NMMA(drug) |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Endpoint Classification: Efficacy Study Intervention Model: Crossover Assignment Masking: Open Label Primary Purpose: Treatment |
Further study details as provided by Dresden University of Technology:
Eligibility| Ages Eligible for Study: | 18 Years to 45 Years |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- healthy subjects
Exclusion Criteria:
- any relevant disease
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00180063
Locations
| Germany | |
| Institute of Clinical Pharmacology, Medical Faculty, University of Technology | |
| Dresden, Germany, 01307 | |
Sponsors and Collaborators
Dresden University of Technology
Investigators
| Study Chair: | Wilhelm Kirch, MD | Institute of Clinical Pharmacology |
More Information
No publications provided by Dresden University of Technology
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| ClinicalTrials.gov Identifier: | NCT00180063 History of Changes |
| Other Study ID Numbers: | IKPD 01-02 Amend LNMMA |
| Study First Received: | September 9, 2005 |
| Last Updated: | November 1, 2005 |
| Health Authority: | Germany: Federal Institute for Drugs and Medical Devices |
Additional relevant MeSH terms:
|
Omega-N-Methylarginine Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action Pharmacologic Actions |
ClinicalTrials.gov processed this record on May 23, 2013